SEC Form 4 · accession 0000318306-15-000022
ABEONA THERAPEUTICS INC. · ABEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
B Davis Jeffrey
Officer — Chief Operating Officer · Director
Period of report
May 11, 2015
Accepted (ET)
May 13, 2015 · 7:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000318306
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1,F2 | May 11, 2015 | A | 300,000 | $7.34 | A | 300,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F2 | $7.34 | May 11, 2015 | A | 100,000 | A | May 11, 2016 | May 11, 2025 | Cpmmon stock | 100,000 | 140,500 | D |
Explanation of responses
- F1300,000 shares of restricted common stock will vest on 5/11/2016.
- F2100% accelerated vesting on change of control.